findmyKOL

Sean Pittock, MD

Enriched profile

Consultant, Department of Neurology; Professor of Neurology, Mayo Clinic College of Medicine and Science; Director, Center for Multiple Sclerosis and Autoimmune Neurology · Mayo Clinic in Rochester

ORCIDNPI
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyNeurologyFocusEpilepsy
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNone verifiedPayments2021–2025NIH funding2010–2014

Sean Pittock is Consultant, Department of Neurology; Professor of Neurology, Mayo Clinic College of Medicine and Science; Director, Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic in Rochester. OpenAlex indexes 762 publications with 53,222 citations (h-index 113); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Sean Pittock, MD, is Consultant, Department of Neurology at Mayo Clinic in Rochester, Minnesota. The public record shows 762 publications with 53,222 citations (h-index 113), centered on Epilepsy. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 12 companies, 1 NIH-funded awards (2010–2014).

  • Most recent indexed publication: 2026 · Annals of neurology
  • Top research focus: Epilepsy
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 12 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neuromyelitis Optica3 trialsMyelitis3 trialsEpilepsy1 trialMultiple Sclerosis1 trialDemyelinating Diseases1 trialOptic Neuritis1 trialNeuritis1 trialMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease1 trial

Research focus

OpenAlex concept fingerprint
Epilepsy

Drugs & molecules

across trials, industry payments and publications
Solirisgeneric · EculizumabClinical trialsIndustry payments23Publications3Upliznageneric · InebilizumabClinical trialsIndustry payments24Publications1Ultomirisgeneric · RavulizumabClinical trialsIndustry payments19Publications

Works with

trial sponsors and companies reporting payments
Alexion Pharmaceuticals, Inc.Clinical trialsIndustry payments55Horizon Therapeutics plcClinical trialsIndustry payments21F. Hoffmann-La Roche AGClinical trialsIndustry payments20

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
762publications

Distinct works indexed by OpenAlex, matched via ORCID; 89 in PubMed.

53,222citations

Total citations across indexed works.

113h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
12companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2010–2014

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    100%
    Potassium Channel Blocker100%
    Firdapse100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 20102014 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org
  • MB (Bachelor of Medicine)

    University College Dublin, National University of Ireland

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org
  • Board Certified

    Neurology, American Board of Psychiatry and Neurology (ABMS)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com

Editorial & leadership roles

journal and society appointments
  • Founder

    Autoimmune Neurology Clinic, Mayo Clinic

    2006
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org
  • Director

    Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic (Marilyn A. Park and Moon S. Park, M.D., Director)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org
  • Director

    Neuroimmunology Laboratory, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
2 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Joint appointment

    Department of Laboratory Medicine and Pathology, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org
  • Medical Advisory Board

    Autoimmune Encephalitis Alliance

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aealliance.org

Media & interviews

press, podcasts and appearances
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.